Haleon plc ( HLN) - Key Metrics
HLN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.27 | $0.17 | $0.20 | $0.18 |
| 2025Q4 | $1.24 | $0.19 | $0.33 | $0.28 |
| 2025Q2 | $1.21 | $0.18 | $0.25 | $0.23 |
| 2025Q1 | $0.61 | $0.09 | $0 | $0 |
| 2024Q4 | $1.20 | $0.16 | $0 | $0 |
HLN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 57.22% | 10.21 |
| 2025Q4 | 24.41% | 9.72 |
| 2025Q2 | 51.49% | 10.58 |
| 2025Q1 | 0% | 22.32 |
| 2024Q4 | 0% | 12.22 |
HLN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 2.53% | 1.41% |
| 2025Q4 | 3.76% | 0.63% |
| 2025Q2 | 3.02% | 1.21% |
| 2025Q1 | 0% | 0% |
| 2024Q4 | 0% | 0% |
HLN
Price: $8.80
Dividend Yield: 1.41%
Forward Dividend Yield: 1.46%
Payout Ratio: 33.17%
Dividend Per Share: 0.12 USD
Earnings Per Share: 0.49 USD
P/E Ratio: 20.31
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United Kingdom
Volume: 23.3 million
Market Capitalization: 38.8 billion
Average Dividend Frequency: 2
Years Paying Dividends: 4